Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Serum amyloid A expression in liver promotes synovial macrophage activation and chronic arthritis via NFAT5
Meiling Li, … , Donghyun Kim, Wan-Uk Kim
Meiling Li, … , Donghyun Kim, Wan-Uk Kim
Published March 1, 2024
Citation Information: J Clin Invest. 2024;134(5):e167835. https://doi.org/10.1172/JCI167835.
View: Text | PDF
Research Article Autoimmunity Inflammation

Serum amyloid A expression in liver promotes synovial macrophage activation and chronic arthritis via NFAT5

  • Text
  • PDF
Abstract

Nuclear factor of activated T-cells 5 (NFAT5), an osmo-sensitive transcription factor, can be activated by isotonic stimuli, such as infection. It remains unclear, however, whether NFAT5 is required for damage-associated molecular pattern–triggered (DAMP-triggered) inflammation and immunity. Here, we found that several DAMPs increased NFAT5 expression in macrophages. In particular, serum amyloid A (SAA), primarily generated by the liver, substantially upregulated NFAT5 expression and activity through TLR2/4-JNK signalling pathway. Moreover, the SAA-TLR2/4-NFAT5 axis promoted migration and chemotaxis of macrophages in an IL-6– and chemokine ligand 2–dependent (CCL2-dependent) manner in vitro. Intraarticular injection of SAA markedly accelerated macrophage infiltration and arthritis progression in mice. By contrast, genetic ablation of NFAT5 or TLR2/4 rescued the pathology induced by SAA, confirming the SAA-TLR2/4-NFAT5 axis in vivo. Myeloid-specific depletion of NFAT5 also attenuated SAA-accelerated arthritis. Of note, inflammatory arthritis in mice strikingly induced SAA overexpression in the liver. Conversely, forced overexpression of the SAA gene in the liver accelerated joint damage, indicating that the liver contributes to bolstering chronic inflammation at remote sites by secreting SAA. Collectively, this study underscores the importance of the SAA-TLR2/4-NFAT5 axis in innate immunity, suggesting that acute phase reactant SAA mediates mutual interactions between liver and joints and ultimately aggravates chronic arthritis by enhancing macrophage activation.

Authors

Meiling Li, Yu-Mi Kim, Jung Hee Koh, Jihyun Park, H. Moo Kwon, Jong-Hwan Park, Jingchun Jin, Youngjae Park, Donghyun Kim, Wan-Uk Kim

×

Figure 7

CCL2 is responsible for arthritis progression as a target of the SAA/NFAT5 axis.

Options: View larger image (or click on image) Download as PowerPoint
CCL2 is responsible for arthritis progression as a target of the SAA/NFA...
(A–C) Quantitation by IHC staining of CCL2 expression in the affected joints of WT (A), Nfat5+/– (B), and LysM-Cre;Nfat5fl/fl mice (C) with SAA-accelerated arthritis (See Supplemental Figure 8A), compared with their respective controls. Data represent mean ± SD; *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001 by Mann Whitney U test (A) and unpaired t test (B and C). Scale bars: 500 μm for low magnification (left panel) and 50 μm for high magnification (right panel). (D) Immunofluorescence colocalization for F4/80 (green) with CCL2 (red) in the affected joints of Nfat5fl/fl versus LysM-Cre; Nfat5fl/fl mice with SAA-accelerated arthritis. Nuclei were counterstained with DAPI (blue). The bar graphs represent mean ± SD. *P < 0.05 by Mann Whitney U test for immunostaining of F4/80+ cells and Kruskal-Wallis test with post hoc Mann-Whitney U test for immunostaining of CCL2+ cells. Scale bars: 20 μm. (E) Histological severity of the affected joints of LysM-Cre;Nfat5fl/fl mice injected intraarticularly with CCL2 (2 μg × 3) versus vehicle alone. The Nfat5fl/fl mice with SAA-accelerated arthritis were used as a positive control. Mean histological severity is shown on the right. Data are mean ± SD. *P < 0.05 and **P < 0.01 by Kruskal-Wallis test with a Dunn’s multiple comparisons test. Scale bars: 500 μm. Data are representative of 2 independent experiments. (F) Quantitation of F4/80+ macrophage and NIMP-R14+ neutrophil infiltration in the affected joints between LysM-Cre;Nfat5fl/fl mice injected intraarticularly with CCL2 (2 μg × 3) and those with vehicle alone. The bar graph indicates mean ± SD. *P < 0.05 and **P < 0.01 by 1-way ANOVA with Tukey’s multiple comparisons test for immunostaining of F4/80 and Kruskal-Wallis test with a Dunn’s multiple comparisons test for immunostaining of NIMP-R14. Scale bars: 50 μm.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts